Efficacy of Nitric Oxide, with or without Continuing Antihypertensive Treatment, for Management of High Blood Pressure in Acute Stroke (ENOS): A Partial-Factorial Randomised Controlled Trial
Lancet 384: doi:10.1016/S0140-6736(14)61121-1, The ENOS Trial Investigators, 2014
Anorexia and Emaciation in Patients with Cerebellar Hemangioblastoma
Neurol 83:1298-1300, Oya, S.,et al, 2014
Posterior Reversible Encephalopathy Syndrome with Spinal Cord Involvement
Neurol 83:2002-2006,1996, de Havenon, A.,et al, 2014
Recognition and Management of Withdrawal Delirium
NEJM 371:2109-2113, Schuckit, M.A., 2014
Enhancing Brain Lesions after Endovascular Treatment of Aneurysms
AJNR 35:1954-1958, Cruz, J.P.,et al, 2014
Brugada Syndrome in Spinal and Bulbar Muscular Atrophy
Neurol 82:1813-1821, Araki, A.,et al, 2014
Traumatic Intracranial Hypertension
NEJM 370:2121-2130, Stocchetti, N. & Maas, A.I.R., 2014
A 24-year-old Woman with Progressive Headache and Somnolence
Neurol 82:e188-e193, Bhattacharyya, S.,et al, 2014
Rebound Intracranial Hypertension: A Complication of Epidural Blood Patching for Intracranial Hypotension
AJNR 35:1237-1240, Kranz, P.G.,et al, 2014
Blurred Vision and Epistaxis
BMJ 348:g91, Shirley, K. & McNicholl, F.P., 2014
Mystery Case: A 63-year-old Man with Progressive Proximal Pain and Weakness
Neurol 82:e26-e29, Scripko, P.D.,et al, 2014
Reperfusion Injury on Magnetic Resonance Imaging After Carotid Revascularization
Stroke 45:602-604, Cho, A.,et al, 2014
4.5-Hour Time Window for Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator is Established Firmly
Stroke 45:912-913,916, Schellinger, P.D. & Kohrmann, M., 2014
The 4.5-HourTime Window for Intravenous Thrombolysis with Intravenous Tissue-Type Plasminogen Activator is Not Firmly Established
Stroke 45:915-915,916, Wechsler, L.R., 2014
Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014
Esophageal Sarcoidosis: A Review of Cases and an Update
ISRN Gastroenterology ID836203, Abraham, A.,et al, 2013
Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage
NEJM 368:2355-2365,2426, Anderson, C.,et al, 2013
Weight Change Associated with Antiepileptic Drugs
JNNP 84:796-799, Pickrell, W.,et al, 2013
Cognitive Outcomes of Patients Undergoing Therapeutic Hypothermia after Cardiac Arrest
Neurol 81:40-45, Fugate, J.,et al, 2013
Results of Intravenous Thrombolysis within 4.5 to 6 Hours and Updated Results within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR)
JAMA Neurol 70:837-844, Ahmed, N.,et al, 2013
A Case-Controlled Comparison of Thrombolysis Outcomes Between Wake-Up and Known Time of Onset Ischemic Stroke Patients
Stroke 44:2226-2231, Manawadu, D.,et al, 2013
Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013
Endovascular Therapy for Asymptomatic Unruptured Intracranial Aneurysms
Stroke 44:2735-2742, Shigematsu, T.,et al, 2013
Revised Diagnostic Criteria for the Pseudotumor Cerebri Syndrome in Adults and Children
Neurol 81:1159-1165, Friendman, D.I.,et al, 2013
A 62-Yeal-Old Man with Fluctuating Neurological Deficits and Skin Lesions
JAMA Neurol 70:120-124, Konikkara, J.,et al, 2013
Clinical Course of Idiopathic Intracranial Hypertension with Transverse Sinus Stenosis
Neurol 80:289-295, Riggeal, B.,et al, 2013
Clinical Reasoning: A 44-year-old Woman with Headache followed by Sudden Neurologic Decline
Neurol 80:e136-e141, Berkowitz, A.L.,et al, 2013
Autoimmune Chorea in Adults
Neurol 80:1133-1144, OToole, O.,et al, 2013
Endovascular Treatment for Acute Ischemic Stroke-Still Unproven
NEJM 368:952-955, Chimowitz,M., 2013
A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
NEJM 368:914-923,952, Kidwell, C.S.,et al, 2013
Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
NEJM 368:893-903,952, Broderick, J.P.,et al, 2013
Pediatric Intracerebral Hemorrhage
JAMA Neurol 70:448-454,437, Beslow, L.et al, 2013
Retrospective Review of Cerebral Mycotic Aneurysms in 26 Patients: Focus on Treatment in Strongly Immunocompromised Patients with a Brief Literature Review
AJNR 34:823-827, Allen, L.M.,et al, 2013
Prehospital Thrombolysis in Acute Stroke
Neurol 80:163-168, Weber, J.,et al, 2013
Treatment of Patients with Suspected Ischemic Stroke of Undetermined Onset and Negative Head Computed Tomography Scan
Stroke 44:1494-1495, Adams, H., 2013
A Plain Computed Tomography Scan is Sufficient to Consider Thrombolysis in Patients with Unknown Time of Onset
Stroke 44:1492-1493, Alexandrov, A., 2013
Clinicopathologic Conferences, Celiac Disease, Addisons Disease, and Major Depression Disorder
NEJM 368:2015-2024, Case 16-2013, 2013
Polymyalgia Rheumatica
Lancet 381:63-72, Kermani, T. & Washington, K., 2013
Brainstem Abnormalities and Vestibular Nerve Enhancement in Acute Neuroborreliosis
BMC Res Notes 6:551, Farshad-Amacker,N.A.,et al, 2013
Meningoencephalitis from Borrelia Miyamotoi in an Immunocompromised Patient
NEJM 368:240-245, Gugliotta, J.L.,et al, 2013
Black Tongue Due to Adrenocortical Insufficiency
Arch Dis Child 97:1033, de Benedictis, F.M.,et al, 2012
Addisons Disease
Contemp Clin Dent 3:484-486, Sarkar, S.B.,et al, 2012
Guillain-Barre Syndrome Associated with Normal or Exaggerated Tendon Reflexes
J Neurol 259:1181-1190, Yuki, N.,et al, 2012
Intracranial Dural Arteriovenous Fistulas: Classification, Imaging Findings, and Treatment
AJNR 33:1007-1013, Gandhi, D.,et al, 2012
Time is Brain(stem) in Basilar Artery Occlusion
Stroke 43:3003-3006, Vergouwen, M.D.I.,et al, 2012
Adult-Onset Opsoclonus-Myoclonus Syndrome
Arch Neurol 69:1598-1607, Klaas, J.,et al, 2012
Clipping Versus Coiling for Ruptured Intracranial Aneurysms
Stroke 44:29-37, Li, H.,et al, 2012
Ischemic Brain Injury After Intracerebral Hemorrhage
Stroke 43:2258-2263, Prabhakaran, S. & Naidech, A.M., 2012
Three-day CSF drainage barely reduces ventricular size in normal pressure hydrocephalus
Neurol 79:237-242, Lenfeldt, N.,et al, 2012
The Benefits and Harms of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator within 6 h of Acute Ischaemic Stroke (the third international stroke trial IST-3): a Randomised Controlled Trial
Lancet 379: 2320, IST-3 collaborative group, 2012